A coordinated network of molecular circadian clocks in individual cells generates 24-hr rhythms in liver metabolism and proliferation. Circadian disruption through chronic jet lag or Per2 clock gene mutation was shown to accelerate hepatocarcinoma development in mice. As divergent effects were reported for clock genes Per and Cry regarding xenobiotic toxicity, we questioned the role of Cry1 and Cry2 in liver carcinogenesis. Male WT and Cry1
A coordinated network of molecular circadian clocks in individual cells generates 24-hr rhythms in liver metabolism and proliferation. Circadian disruption through chronic jet lag or Per2 clock gene mutation was shown to accelerate hepatocarcinoma development in mice. As divergent effects were reported for clock genes Per and Cry regarding xenobiotic toxicity, we questioned the role of Cry1 and Cry2 in liver carcinogenesis. Male WT and Cry1
2/2

Cry2
2/2 mice (C57Bl/6 background) were chronically exposed to diethylnitrosamine (DEN) at ZT11. Rest-activity and body temperature rhythms were monitored using an implanted radiotransmitter. Serum aspartate and alanine aminotransferases (AST and ALT) were determined on four occasions during the progression stage. After 7 months, serum alkaline phosphatases (ALP) were determined, and livers were sampled for microscopic tumor nodule counting and histopathology. Five months after initiation of DEN treatment, we found that Cry1 2/2 Cry2 2/2 mice developed severe liver dysplasia, as evident from the increased AST, ALT and ALP levels, as compared to WT mice. DEN exposure induced primary liver cancers in nearly fivefold as many Cry1 2/2 Cry2 2/2 mice as compared to WT mice (p 5 0.01). Microscopic study revealed no difference in the average number of hepatocarcinomas and a nearly eightfold increase in the average number of cholangiocarcinomas in Cry1 2/2 Cry2 2/2 mice, as compared to WT mice. This study validated the hypothesis that molecular circadian clock disruption dramatically increased chemically induced liver carcinogenesis. In addition, the pronounced shift toward cholangiocarcinoma in DEN exposed Cry1 2/2 Cry2 2/2 mice revealed a critical role of the Cry clock genes in bile duct carcinogenesis.
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) constitute the vast majority of primary liver cancers, the third cause of cancer-related mortality worldwide. These liver cancers are derived from the respective malignant transformation of hepatocytes and bile duct epithelial cells. 1, 2 Diethylnitrosamine (DEN) is a hepatic carcinogen that usually induces HCC in rodents, which have been considered as a good reflection of poor prognosis human HCC. 3 DEN also induces CCA in mice with bile duct ligation. 4, 5 In this study, we used DEN as a liver cancer initiator and promoter to investigate the role of circadian genes Cry1 and Cry2 for liver carcinogenesis in mice.
The mammalian circadian timing system (CTS) regulates behavioral and physiological processes over 24 hr. Endogenous circadian rhythms are mainly synchronized to the regular day-night cycle by light. The liver is one of the most rhythmic organs in the body. Prior studies show that approximately 15% of liver transcriptome and proteome display circadian variations. 6, 7 In addition, a wide range of critical liver metabolic pathways is controlled by the circadian clock, involving amino acid, carbohydrate, lipid, nucleotide and xenobiotic metabolism. 8, 9 The CTS is coordinated by the suprachiasmatic nucleus (SCN) in the hypothalamus, which acts as a central pacemaker. The SCN generates rhythmic physiology and coordinates molecular circadian clocks in peripheral organs, including the liver. 10, 11 The molecular clock, which resides within almost all cells, consists of at least three interconnected transcription-translation feedback loops (TTFL) that control rhythmic gene expression patterns with a near 24-hr period. 12 The core TTFL is driven by activator proteins BMAL1 and CLOCK or NPAS2, which activate the transcription of target genes containing E-box cis-regulatory enhancer sequences, including Period (Per) 1, 2 and 3 genes and Cryptochrome (Cry) 1 and 2 genes. In turn, PER::CRY protein heterodimers accumulate in the nucleus and suppress transcription of their own genes by acting on the CLOCK::BMAL1 protein complex, and as such form the main inhibitory loop of the TTFL.
11
Several epidemiologic studies, as well as an international expertise by the World Health Organisation, have concluded that "shift-work that involves circadian disruption is probably carcinogenic to humans. 13, 14 " Indeed, circadian disruption promotes tumor initiation and accelerates experimental cancer progression in mice with SCN ablation, experiencing chronic jet lag or circadian gene mutations, while oppositely CTS reinforcement with meal timing inhibits cancer growth. [15] [16] [17] [18] [19] [20] Host circadian disruption was further associated with fast tumor progression and poor survival in cancer patients. 21, 22 . Circadian disruption induced by Per2 mutation, constant light or chronic jet lag exposure has been shown to promote DEN-induced liver carcinogenesis, resulting in increased formation of a majority of HCC and few CCA in rats and mice.
23-25 DEN is usually used for liver cancer initiation (2-4 weeks of DEN exposure) and induces the formation of dysplastic foci with altered hepatocytes. Prolonged DEN administration is used to act as a cancer promoter (Week 4-10), and induces irreversible hepatocellular nodules. 26, 27 Recently, it has been shown that Per2 clock gene acts as a tumor suppressor in the liver of mice exposed during 7 weeks to DEN. Per2 mutation accelerates hepatocarcinogenesis through uncontrolled proliferation, genomic instability and tumor promoting inflammation. This mutation increases HCC several folds without any significant effect on CCA development.
25
Cry1 and Cry2 are involved in the negative loop of the circadian molecular clock. They are robustly expressed and rhythmic in the mouse liver. 16, 25 Thus, the combined inactivation of Cry1 and Cry2 in mice suppressed rest-activity, core body temperature and corticosterone secretion following constant darkness exposure. 28, 29 The lack of CRY proteins, as in Cry1/Cry2 double-deficient mice, suppressed the rhythmic expressions of Per1 and Per2 30 and other E-Box clock or clock-controlled genes. 6, 31 In addition, Cry1 and Cry2 genes displayed lower RNA messenger expression, phase shift and dampened amplitude during the initiation stage in the liver of WT and Per2 mutant mice exposed to DEN. 25 To further test the clock disruption hypothesis as a liver co-carcinogen, we hypothesized that chronic exposure to DEN would enhance the rate of liver cancers in mice with Cry1/Cry2 double deficiency as compared to WT mice exposed to the same dose of DEN. We show that Cry1/Cry2 deficiency increased liver carcinogenesis nearly fivefold and caused a very pronounced shift in tumor spectrum from HCC to CCA.
Material and Methods
Mice and study design
This study was conducted in accordance with the guidelines approved for animal experimental procedures by the French Ethical Committee (decree 87-848).
The effect of Cry1/Cry2 deficiency for DEN-induced liver cancer was investigated in male C57Bl/6 mice. Eighteen wildtype (WT) and 17 Cry1 Shift-work that involves circadian disruption has been declared probably carcinogenic to humans. Here, the relevance of the circadian clock in liver carcinogenesis was investigated through exposing Cry1/Cry2-deficient mice to hepatic carcinogen diethylnitrosamine (DEN). Cry1/Cry2 deficiency increased liver carcinogenesis nearly fivefold, validating the hypothesis that molecular circadian clock disruption dramatically increased chemically induced liver carcinogenesis. In addition, the pronounced shift in tumor spectrum from hepatocarcinoma to cholangiocarcinoma in DEN-exposed Cry1 2/2 Cry2 2/2 mice revealed a critical role of the Cry clock genes in bile duct carcinogenesis. The findings emphasize the role of the two clock genes in the yet poorly understood physiopathology of cholangiocarcinogenesis.
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daily from Day 43 to 68. Body weight was recorded daily before each DEN injection and three times a week thereafter. Mortality was checked daily throughout the experiment. Blood was sampled from the retro-orbital sinus on days 142, 164, 186 and 211, that is, during the progression stage. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were determined four times during the progression stage in the sera using a Synchron LX20 Clinical System (Beckman Coulter, Villepinte, France). Alkaline phosphatases (ALP) serum levels were measured at the last sampling time point. We considered that Day 1 to Day 21 corresponded to the initiation stage, Day 22 to Day 68 to the promotion stage and Day 69 and thereafter to the progression stage. All the mice were euthanized 211 days after DEN exposure onset. Livers, kidneys and lungs were removed for pathology and histological studies.
Circadian biomarkers
Prior to DEN treatment, a Physio Tel TA 10 TA-F20 radiotransmitter (Data Sciences, St. Paul, Minnesota) was implanted into the peritoneal cavity under isoflurane anesthesia in 28 mice, that is, 14 Cry1 2/2 Cry2 2/2 and 14 WT. These telemetric sensors recorded the rest-activity and body temperature rhythms every 10 min for 5 days before DEN exposure and for 150 days thereafter.
Histological studies
Immediately after sacrifice, mice were autopsied and macroscopic tumor nodules were counted. Liver, lungs and kidneys were collected from each mouse for serial histological slides. All tissues were fixed with 4% formaldehyde for 24 hr, dehydrated and embedded in paraffin. Then, three 4-mm-thick sections were obtained 1 mm apart in each liver and stained with hematoxylin-eosin-saffron. Slides were examined blindly for the presence and the type of microscopic tumor nodules by a senior pathologist (C.G.).
Data analyses
Quantitative data were expressed as mean 6 standard error of the mean (SEM). Intergroup differences were compared using multiple-way analyses of variance (ANOVA), v 2 , T-student and log-rank tests, according to data characteristics. Body temperature and activity data were obtained using Dataquest software. The statistical significance of sinusoidal rhythmicity was documented by cosinor analysis. This method estimates the rhythm characteristics: mesor (24-hr mean), amplitude (half of the difference between maximum and minimum value of fitted cosine function) and acrophase (time of maximum in fitted cosine function, with light onset as phase reference). A rhythm period s 5 24 hr was considered a priori. A p value < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS statistical analysis software version 18 (Statistical Package for Social Sciences, Chicago, IL).
Results
Systemic toxicity of DEN in WT and Cry1 (Fig. 1e) .
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Baseline rest-activity and body temperature patterns in WT and Cry1
2/2
Cry2 2/2 mice before DEN exposure and throughout the liver carcinogenesis process
Rest-activity and body temperature circadian biomarkers were recorded by telemetry, starting 5 days before DEN exposure onset and continuing until 150 days after it. Prior to carcinogen administration, regular 24-hr changes were found for rest-activity and body temperature in WT mice. The 24-hr patterns in both variables were severely altered in Cry1 2/2 Cry2 2/2 mice (Fig. 2a) . As a result, cosinor analysis validated statistically significant rhythms, with different characteristics according to genotype. Thus, a phase advance was found in Cry1 2/2 Cry2 2/2 mice by 3 hr and 10 min for restactivity (ZT15:40 vs ZT18:50; p < 0.001) and by 1 hr and 50 min for body temperature (ZT16:20 vs ZT18:10; p 5 0.025) as compared to WT (Fig. 2b) . The circadian amplitude was nearly reduced by half for both rest-activity (Hoteling t test for amplitude comparisons, 1.05 6 0.27 vs 2.09 60.22 arb. units, p < 0.001), and body temperature (0.53 6 0.07 vs 0.96 6 0.028C, p < 0.001) in Cry1 2/2 Cry2 2/2 animals as compared to WT mice (Fig. 2c) . In Cry1
Cry2 2/2 mice, DEN administration suppressed the circadian rhythm in rest-activity for 6/14 mice (40%) and that in body temperature for 4/14 animals (28%) during the initiation and/or promotion and progression stages. In contrast, no circadian rhythm loss was observed for both variables in WT mice. Interestingly, the rest-activity and/or temperature circadian rhythms were completely suppressed during the initiation/promotion stages for four of the six Cry1 2/2 Cry2 2/2 mice, which subsequently died before study completion. During the initiation stage, DEN exposure further advanced the rest-activity circadian phase by 2 hr in WT (p < 0.001), without any significant alteration in Cry1 2/2 Cry2 2/2 mice as compared to baseline values before DEN exposure. In contrast, the temperature circadian phase was advanced by 1 hr in WT and 1 hr and 30 min in Cry1 2/2 Cry2 2/2 mice (paired t test, p < 0.001) (Fig. 2b) . In WT animals, DEN halved the circadian amplitude for rest-activity and damped it by 20% for body temperature as compared to their respective baseline values (Hoteling t test for amplitude comparisons, p < 0.001 and p 5 0.03). The circadian amplitude for rest-activity rhythm 
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was halved in DEN treated Cry1 2/2 Cry2 2/2 mice (p 5 0.003) while it was 1.6-fold lower for body temperature rhythm as compared to baseline values (Fig. 2c) .
A nearly 1-hr phase advance was statistically confirmed during the promotion stage for both rest-activity and body temperature rhythms in WT mice (p 5 0.09 and p < 0.001) as compared to their baseline values before DEN exposure. Cry1 2/2 Cry2 2/2 mice did not display any significant change for rest-activity phase, while cosinor analysis validated a 2-hr phase advance for body temperature (ZT16:20 vs ZT14:30, p 5 0.03) (Fig. 2b) . During this carcinogenesis stage, DEN dampened the circadian amplitude by 37% and 15% for both rest-activity and body temperature rhythms, respectively, in WT mice (p 0.001). Moreover, this effect was more pronounced in Cry1 2/2 Cry2 2/2 mice, and the circadian amplitude was nearly halved for both rhythms (p 5 0.01 for restactivity, and p 5 0.03 for body temperature) (Fig. 2c) . After DEN exposure, the circadian acrophases and amplitudes of both rhythms recovered back to baseline values in the mice from both genotypes. Double-plot representations of both body temperature and rest-activity rhythms in individual mice over 130 days showed stable rhythms in WT controls mice and markedly damped, yet persistent rhythms in control Cry1 2/2 Cry2 2/2 animals (Fig. 3) . Indeed, the daily intraperitoneal injections of the control solution induced minimal if any alteration in the rest-activity and intraperitoneal temperature patterns in both control WT and both control Cry1 2/2 Cry2 2/2 mice, which matched the corresponding DEN-treated groups (Fig. 3 , Supporting Information, Tables  1 and 2 ). DEN exposure transiently disrupted both circadian rhythms during the initiation and the promotion stages in WT mice. Both rhythms subsequently recovered during the progression stage. In contrast, the disruption of both rhythms was complete and sustained until the end of the recording in Cry1 2/2 Cry2 2/2 mice exposed to the same DEN cumulative dose (Figs. 3a and 3b) . mice, histopathological analysis revealed 24 times as many CCA as compared to HCC (73 vs 3; p < 0.001). However, WT mice did not display any significant difference for liver cancer types (Fig. 5b) . The average number of CCA per mouse was 7.8-fold as high in Cry1 2/2 Cry2 2/2 mice as compared to WT mice (p < 0.01), while no validated difference was detected for HCC (Fig. 5b) .
DEN induced liver carcinogenesis in WT and
Discussion
Here we validated the hypothesis that chronic exposure to DEN enhanced several-fold the rate of liver cancers in mice with a Cry1/Cry2 double deficiency as compared to WT mice exposed to the same dose of DEN. This was consistent with the findings we earlier reported in Per2 m/m mice, which harbored another clock gene deficiency. 25 However, histopathological examination by a senior liver cancer pathologist revealed that the vast majority of liver cancers were cholangiocarcinomas rather than hepatocarcinomas in the Cry1/Cry2 double-deficient mice. To our knowledge, this is the first study that reveals a direct role of Cry1 and Cry2 genes in CCA. Notably, the deficiency of Cry1 and Cry2 caused a nearly eightfold increase in the average number of CCA induced by the hepatic carcinogen DEN in mice.
Cry1 2/2 Cry2 2/2 mice displayed genetic circadian disruption, as indicated by arrhythmic body temperature, restactivity and corticosterone secretion while in constant darkness. 28, 29 However, a 24-hr rhythm in rest-activity and body temperature was found here in Cry1
Cry2
2/2 mice exposed to LD12:12, yet with 2-to 3-hr phase advance and halved amplitude. These apparent rhythms in clock-deficient Cry1 2/2 Cry2 2/2 mice likely originated from direct responses to light, so-called masking effect.
28
Cry1/Cry2 double-deficient mice were also shown to display enhanced susceptibility to develop spontaneous or gamma radiation-induced HCC as compared to WT animals, without any reported evidence of CCA formation in their livers. 19, 32 In contrast, we did find both HCCs and CCAs in WT B6D2F1 mice kept in LD12:12 or chronically exposed to jet lag and receiving DEN, 24 as well as both in WT and in Per2 m/m mice on chronic DEN. 25 This study revealed a low incidence of DEN-induced HCC both in WT and in Cry1/Cry2 doubledeficient mice on C57Bl/6 background. Yet the large and highly statistically significant difference in CCA formation most likely resulted from altered DEN metabolism and toxicodynamics in the Cry1/Cry2 double-deficient mice. The differences in DEN metabolism and toxicodynamics between Cry1/Cry2 double-deficient and Per2 m/m mice thus appeared to be crucial for the cancer type outcomes.
The role of Cry1/Cry2 double deficiency for liver carcinogenesis was here investigated in mice on a C57Bl/6 background, with altered melatonin secretion. Gas chromatography (GC)-mass spectrometry (MS) studies have demonstrated melatonin in the pineal gland and in peripheral blood of C57BL/6, BALB/ c and C57BL/6 x DBA2 (B6D2F1) mice, which were previously deemed to lack any melatonin secretion. 33, 34 However, melatonin secretion was weak, and its circadian pattern was shifted or bimodal, as compared to the prominent melatonin secretory patterns in C3H and CBA mice. 33, 34 Hence, our study could not robustly assess any effect of endogenous melatonin secretion on DEN carcinogenesis, or its impairment in clock-mutant mice. Nonetheless, the anticarcinogenic effects of melatonin against liver carcinogenesis remain an important issue. In rats, melatonin prevented chemically induced hepatocarcinogenesis by reversing the oxidant-antioxidant imbalance during DEN exposure, 35, 36 while in vitro exogenous melatonin-induced apoptosis in CCA cell lines. 37 Interestingly, a Cry1/Cry2 double deficiency has been shown to both decrease mean level and suppress the circadian melatonin secretory pattern in C3H mice. 38 Accordingly, we would expect DEN-induced liver carcinogenesis to be reduced in melatonin-proficient C3H mice, while being doubly enhanced both by circadian clock disruption and melatonin suppression in cryptochromes-deficient C3H mice.
Decreased mRNA or protein expressions of Cry1 and/or Cry2 were reported for human HCC, as well as for human cancers of the breast, endometrium, ovary, prostate, colon, pancreas, head-and-neck, brain, skin and blood cells. [39] [40] [41] [42] Yet, the relevance of Cry1/Cry2 deficiency for carcinogenesis was debated. A prior report showed that Cry1/Cry2 deficiency promoted g-radiation-induced lymphomas in mice. 19 This could result from increased cell cycling, as Cry1 2/2 Cry2 2/2 fibroblasts were shown to proliferate faster than WT fibroblasts. 43 However, both of these latter findings 19, 43 contrasted with another report where Cry1/Cry2 deficiency had no effect on g-radiationinduced carcinogenesis and mortality in mice. 44 This latter finding was also in line with the lack of any upregulation of the proto-oncogene c-Myc in Cry1 2/2 Cry2 2/2 mouse liver and fibroblasts following radiation exposure, as well as the lack of 
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modifications of cell cycle checkpoints, DNA repair or apoptosis in Cry-deficient fibroblasts. 44 Moreover, the combination of Cry1/Cry2 deficiency with p53 deletion protected mice from the early onset of g-radiation-induced cancers and increased their median lifespan. 45, 46 However, our study unambiguously demonstrated a dramatic and unexpected CCA effect of DEN in mice with a Cry1/Cry2 double deficiency. The magnitude of such effect was apparently unrelated to that of DEN toxicity. Thus, body weight loss-a marker of systemic toxicity-was least in Cry1 2/2 Cry2 2/2 mice, a finding consistent with increased tolerability of Cry1
mice to the alkylating drug cyclophosphamide. 47 In contrast, Per2 mutant mice exposed to DEN displayed larger body weight loss as compared to their control. 25 Taken together, the results support CYP-mediated bioactivation of both DEN and cyclophosphamide was decreased in Cry1 impact on initiation stage. This conclusion is also supported by the fact that Cry1/Cry2-deficient mice displayed lower liver regeneration 72 hr after partial hepatectomy, associated with a high level of WEE1, which blocks G2-M transition. 48 DEN-induced liver carcinogenesis involves initial triggering of chronic inflammation. 49, 50 More specifically, CCA risk factors involve chronic biliary inflammation. According to several reports, proinflammatory cytokine IL-6 was upregulated in cultured CCA cells, resulting in the activation of the JAK-STAT and NF-kB signaling pathways. 51 ,52 IL-6 further increased Mcl-1 through STAT-3 activation, and prevented apoptosis in CCA cells. 51, 52 In addition, IL-6 upregulation in CCA dysregulated the cell division cycle through the activation of P38 MAPK. 53 Indeed, several studies showed an important role of NF-kB activation in cholangiocarcinogenesis. 54, 55 The silencing of Cry1 and Cry2 enhanced lipopolysaccharide-induced inflammatory response through increased NF-jB and IL-6 activation in mouse hypothalamus, bone marrow macrophages and fibroblasts. 29, 56 It has been shown that CRY1 protein binds to adenylyl cyclase and induces cAMP downregulation. In Cry1
Cry2
2/2 cells, the inhibition of adenylyl-cyclase leads to cAMP upregulation, PKA activation, P65 (a subunit of NF-kB complex) phosphorylation and activation of NF-kB target genes such as IL-6. 56 Thus, the increased biliary carcinogenesis found in Cry1 2/2 Cry2 2/2 mice exposed could result from an enhanced susceptibility to pre-existing and/or DEN-induced chronic biliary inflammation.
In contrast to the finding showing that Per2 mutant mice are more susceptible to develop HCC, 25 Cry1
2/2
Cry2 2/2 -deficient mice were more sensitive to DEN-induced CCA. WT mice subjected to left median bile duct ligation after 2 weeks of DEN exposure, then exposed to DEN, showed an increased susceptibility to develop CCA. 4 We suggest that the Cry1/Cry2 double deficiency acts-like bile duct ligationthrough accumulation of toxic bile acids in the liver during the promotion stage, and thus would shift the cancer susceptibility of mice from HCC to CCA.
Although toxic bile acid accumulation increased liver susceptibility to develop HCC in animals, bile duct ligationmediated toxic bile acid accumulation has also been shown to enhance CCA development. 57, 58 Bile acid accumulation locally altered proliferation and apoptosis (and even more so during cholestasis), which further predisposed to cholangiocarcinogenesis. 59, 60 Indeed, mice with bile duct ligation exposed to DEN displayed clearly accelerated CCA rather than HCC development. 4 Thus, CCA occurred in 2.5 times as many mice with bile duct ligation as compared to those without such procedure (50% vs 20%), while the rate of HCC remained similar (20%) in both groups. 4 Importantly, the CCA-to-HCC ratio was also largely positive and even greater in Cry1 2/2 Cry2 2/2 versus WT mice in our study, suggesting additional metabolic effects of the cryptochromes double deficiency. Interestingly, the Per1
Per2
2/2 mice whose circadian phenotype closely resembles that of Cry1 2/2 Cry2 2/2 animals displayed elevated serum bile acid levels, while the circadian expression of key bile acid synthesis and transport genes (including Cyp7A1 and NTCP) was lost. 61 In aggregate, these reports and our findings jointly support cholestasis and toxic bile acid accumulation to result from Cry1/Cry2 double deficiency, and to shift DEN liver carcinogenesis from HCC toward CCA formation.
This study has unambiguously validated that circadian clock disruption through Cry1/Cry2 double deficiency more than doubled the incidence of DEN-induced liver cancers, with adequate statistical power. Eight times more CCAs were found in Cry1 2/2
Cry2
2/2 as compared to WT mice, while nearly 10% HCC occurred in both genotypes. We inferred that such major shift from HCC to CCA in the DEN liver carcinogenesis model resulted from accumulated bile acids and cholestasis in the Cry double-deficient mice. 
2/2 mice. ** p < 0.01; ***p < 0.001.
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